跳至主要内容
临床试验/NCT02772133
NCT02772133已完成不适用

Circulating PRCP in STEMI Patients Undergoing Primary PCI

Qilu Hospital of Shandong University4 个研究点 分布在 1 个国家目标入组 275 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
275
试验地点
4
主要终点
Circulating PRCP level

研究概览

简要总结

Purpose: The purpose of this study is to evaluate the impact of acute ST-segment elevation myocardial infarction (STEMI) and primary percutaneous coronary intervention (PCI) on circulating prolylcarboxypeptidase (PRCP) level and activity.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted for primary PCI for STEMI involving the LAD within 12 hours of onset of symptoms. STEMI will be defined as typical ECG changes (ST segment elevation ≥2mm in 2 or more precordial leads) associated with acute chest pain or an elevation of cardiac enzymes;
  • Age ≥18 years;
  • Informed consent from subject or next of kin.

排除标准

  • Nonischaemic Cardiomyopathy;
  • Cardiac surgery planed in the 6 months;
  • Mechanical complication of STEMI (ventricular septal rupture, free wall rupture, acute severe mitral regurgitation);
  • Renal or hepatic failure;
  • Malignancy, HIV, or central nervous system disorder;
  • Cardiopulmonary resuscitation >15 min and compromised level of consciousness;
  • Cardiogenic shock;
  • Current participation in any research study involving investigational drugs or devices;
  • No written consensus;
  • Previous myocardial infarction.

结局指标

主要结局

Circulating PRCP level

时间窗: 1 month

Circulating PRCP activity

时间窗: 1 month

次要结局

  • Circulating BK-(1-9) level(1 month)
  • Circulating KBK-(1-9) level(1 month)
  • Circulating Ang II level(1 month)
  • Circulating Ang-(1-7) level(1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pan-Pan Hao

MD, PhD

Qilu Hospital of Shandong University

研究点 (4)

Loading locations...

相似试验

Circulating PRCP in STEMI Patients Undergoing... | 临床试验